FDA REMS Platform Will Make Safety Plans Easy – Maybe Too Easy?
This article was originally published in The Pink Sheet Daily
Executive Summary
There is concern that common software package could mean more drugs end up with risk management programs.
You may also be interested in...
REMS Integration Into Electronic Health Records To Be Tested By US FDA In Software Pilot
The prototype pulls information from the electronic record to fill out enrollment and other forms, but stakeholders say it must work for most, if not all, REMS drugs in order to be widely used.
REMS Standardization Could Help Opioid Education Efforts
FDA hopes to begin accepting Risk Evaluation and Mitigation Strategy documents in structured product labeling format later this year.
PDUFA VI: BIO Survey Finds FDA Communication Problems
Data may help industry stake out its negotiating position as formal talks near for user fee reauthorization.